Sign in

CIK 0001062822 · Non-accelerated filer<br>Smaller reporting company

LEXICON PHARMACEUTICALS, INC.

Sign in to watch
Ticker
LXRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
760474169
Phone
2818633000
Business address
2445 TECHNOLOGY FOREST BLVD., SUITE 1100, THE WOODLANDS, TX, 77381
Former names
LEXICON PHARMACEUTICALS, INC./DE, LEXICON GENETICS INC/TX
Open-market buys, last 90 days
$49,999
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$49,999. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Exton Michael +$50K Chief Executive Officer 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-02-28 Crum Brian T SVP, General Counsel & Secr. Option exercise +33,456 237,050
2025-02-28 Crum Brian T SVP, General Counsel & Secr. Option exercise +69,387 306,437
2025-02-28 Crum Brian T SVP, General Counsel & Secr. Shares withheld for taxes −45,622 $0.67 $31K 260,815
2025-02-28 Crum Brian T SVP, General Counsel & Secr. Option exercise · Restricted Stock Units −26,097 0
2025-02-28 Crum Brian T SVP, General Counsel & Secr. Option exercise · Restricted Stock Units −33,456 33,457
2025-02-28 Crum Brian T SVP, General Counsel & Secr. Option exercise · Restricted Stock Units −69,387 138,773
2025-02-13 Alexander Kristen VP, Finance and Accounting Grant or award · Stock Option (Right to Buy) +185,540 185,540
2025-02-13 Alexander Kristen VP, Finance and Accounting Grant or award · Restricted Stock Units +185,540 185,540
2025-02-13 McDermott Wendy SVP, Human Resources Grant or award · Stock Option (Right to Buy) +649,780 649,780
2025-02-13 McDermott Wendy SVP, Human Resources Grant or award · Restricted Stock Units +433,180 433,180
2025-02-13 MAIN ALAN J EVP, Innov & Chem Sciences Grant or award · Stock Option (Right to Buy) +753,090 753,090
2025-02-13 MAIN ALAN J EVP, Innov & Chem Sciences Grant or award · Restricted Stock Units +502,060 502,060
2025-02-13 Granowitz Craig B SVP, Chief Medical Officer Grant or award · Stock Option (Right to Buy) +910,170 910,170
2025-02-13 Granowitz Craig B SVP, Chief Medical Officer Grant or award · Restricted Stock Units +606,780 606,780
2025-02-13 DeFrancesco Lisa VP, IR and Corp Comm Grant or award · Stock Option (Right to Buy) +576,850 576,850
2025-02-13 DeFrancesco Lisa VP, IR and Corp Comm Grant or award · Restricted Stock Units +384,570 384,570
2025-02-13 Crum Brian T SVP, General Counsel & Secr. Grant or award · Stock Option (Right to Buy) +765,730 765,730
2025-02-13 Crum Brian T SVP, General Counsel & Secr. Grant or award · Restricted Stock Units +510,490 510,490
2025-02-13 Corrigan Brian SVP, Regulatory & QA Grant or award · Stock Option (Right to Buy) +673,000 673,000
2025-02-13 Corrigan Brian SVP, Regulatory & QA Grant or award · Restricted Stock Units +448,660 448,660

Page 9 of 15 · 285 trades